Fidelity Strategic Dividend & Income benefits from effective collaboration between highly skilled managers and research teams. Comanager Ford O’Neil will retire in September 2026, but the remaining team is well prepared to execute the rigorous and repeatable investment process he helped set up. Combined with reasonable fees (depending on the share class), this strategy remains a compelling choice for investors who seek a nontraditional income portfolio.
Fidelity Advisor Strategic Dividend & Income Fund - Class M FTSDX
- NAV / 1-Day Return 19.01 / −0.11 %
- Total Assets 5.6B
-
Adj. Expense Ratio
1.170%
- Expense Ratio 1.170%
- Distribution Fee Level Above Average
- Share Class Type Front Load
- Category Moderately Aggressive Allocation
- Investment Style Large Value
- Credit Quality / Interest Rate Sensitivity Medium/Moderate
- Status Open
- TTM Yield 1.77%
- Turnover 41%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:11 AM GMT+0
Morningstar’s Analysis FTSDX
Will FTSDX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 21.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Convertible Sub-Portfolio Positions | 15.93 | 928M | — |
ExxonMobil Holdings Corp | 2.99 | 174M | Energy |
Fidelity Cash Central Fund | 2.80 | 163M | Cash and Equivalents |
AbbVie Inc | 2.62 | 153M | Healthcare |
Cisco Systems Inc | 2.41 | 141M | Technology |
Johnson & Johnson | 2.34 | 136M | Healthcare |
Coca-Cola Co | 2.13 | 124M | Consumer Defensive |
Samsung Electronics Co Ltd | 2.05 | 119M | Technology |
Procter & Gamble Co | 1.91 | 111M | Consumer Defensive |
Merck & Co Inc | 1.79 | 104M | Healthcare |